Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Enteroviral infections with antiCD20 therapies-A class effect?
Game-based and gamification-enhanced telerehabilitation for physical therapy in people with multiple sclerosis: a scoping review.
Epigenetic and genetic insights for tailored therapeutic strategies in multiple sclerosis.
Neuronal expression of β2M and MHC I are essential for peripheral surveillance and targeting of neuron-restricted antigens.
Glatiramer Acetate Therapy Induces DNA Methylation Changes in Immune Cells of Multiple Sclerosis Patients: A Pilot Study.
Th1/Th17-linked transcription factors TBX21 and RORC were associated with clinical response to rituximab in treatment-resistant schizophrenia.
Visual and Neuro-Ophthalmic Manifestations of John Cunningham (JC) Virus-Related Natalizumab-Associated Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Systematic Review.
Real-World, Long-Term Outcomes with Cladribine Tablets Versus Other Oral Treatments Among Patients with Multiple Sclerosis.
Quantitative MRI metrics associated with lesion evolution in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Peripheral Myelin Protein-22 and Its Prominence in Charcot-Marie-Tooth Disease.
Psychometric evaluation of the L Test for functional mobility across EDSS-based severity levels in multiple sclerosis.
Uncovering the role of microRNAs in response to interferon-beta therapy among multiple sclerosis patients: A systematic review.
Synaptic alterations are preceding the axonal loss in optic atrophy of Wolfram syndrome mouse model.
A practical alternative to live cell-based assay for AQP4 and MOG antibody detection.
Home-based exoskeleton use to improve quality of life in patients with multiple sclerosis: study protocol of a multicentre, randomised, cross-over trial.
Development and Validation of Cell-Based Bioassay for the Detection of Neutralizing Antibodies to Ocrelizumab in Human Serum Using Antibody-Dependent Cell-Mediated Cytotoxicity Test in a Reporter Cell Line Expressing FcγRIIIa.
Neurotherapeutic roles of the protective arm of the renin-angiotensin system: from inflammation to cognitive rescue.
Fer-1 improves cognitive dysfunction in chronic kidney disease through the Sirt2/PGC-1α signaling pathway based on RNA sequencing.
Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders.
Advances in nanotechnology for the diagnosis and management of autoimmune diseases.
Association of vitamin B1/B6/B12 supplementation with sphingosine-1-phosphate signaling and its receptors in multiple sclerosis patients: relevance to LISPR1 and APOA1-AS.
Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis.
Antinuclear antibody and delayed immunotherapy predict disease evolution in isolated optic neuritis-onset NMOSD: A long-term cohort study.
Feasibility and Validity of a Remotely-Administered 30-Second Sit-to-Stand in People with Multiple Sclerosis.
Benefits of a Perceived High-Intensity Exercise Program with Immersive Virtual Reality Combined with Usual Rehabilitation in Multiple Sclerosis: Exploratory Study.

Pages